TrialArthritis & rheumatology (Hoboken, N.J.)2025

Topical Mupirocin Treatment Reduces Interferon and Myeloid Signatures in Cutaneous Lupus Erythematous Lesions Through Targeting of Staphylococcus Species.

Lisa Abernathy-Close et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.